期刊文献+

超声造影在卵巢肿瘤良恶性鉴别诊断中的应用 被引量:6

Applications of Contrast-enhanced Ultrasound in Differentiating Ovarian Malignant Tumors from Benign Tumors
暂未订购
导出
摘要 目的探讨卵巢良恶性肿瘤的超声造影增强表现。方法超声造影采用编码相位反转技术,对30例常规超声检查发现附件区囊实混合性肿物或实性肿物的患者进行超声造影检查,分析其造影增强特征。结果卵巢良恶性肿瘤超声造影增强表现不同,卵巢良性肿瘤显示瘤体均匀性增强,多数从周边向内部灌注,可见血管形态规则;而恶性肿瘤显示瘤体不均匀性增强,多数以血管为中心向瘤体内部灌注,可见粗大、扭曲、走向不规则的供养血管呈蟹足样或树枝状穿入瘤内。结论卵巢良恶性肿瘤的超声造影增强表现不同,有助于卵巢肿瘤良恶性鉴别及早期卵巢癌的发现。 Objective To discuss the enhanced appearance of contrast - enhanced ultrasound on ovarian benign tumors and malignant tumors. Methods 30 women with suspected complex adnexal masses agreed to undergo contrast - enhanced ultrasound (CEUS) examination by use of the Cede PI mode. The enhancement appearance of CEUS was observed on tumors. Results The enhanced appearance of contrast - enhanced ultrasound on malignant tumors and benign tumors is different. The benign ovarian tumors take on the enhancement of contrast agent regularly from periphery into centre and show normal vessel calibers, while malignant tumors take on the enhancement irregularly on vascular as centre and show heterogeneous features including bulky, tortuous, irregular calibe.r vascular pattern which look like crab feet or branches. Conclusions The enhanced appearance of contrast - enhanced ultrasound on malignant tumors and benign tumors is different, which is helpful in differentiating ovarian malignant tumors from benign tumors and finding ovarian cancer in earlier period.
出处 《辽宁医学院学报》 CAS 2008年第6期511-513,共3页 Journal of Liaoning Medical University (LNMU) Bimonthly
关键词 卵巢肿瘤 超声造影 造影剂 ovarian tumors contrast - enhanced ultrasound contrast agent
  • 相关文献

参考文献10

  • 1[1]Vlasova MA,Moshkovskii SA,Safarova MP,et al.Molecular di-agnostics of ovarian cancer using proteome techniques[J].Bi-omed Khim,2005,51(4):367-383.
  • 2[2]Leen E,Moug SJ,Horgan P.Potential impact and utilization of ultrasound contrast media[j].Eur Radiol,2004,14(Supple8):16-24.
  • 3[3]Leen E.The role of contrast-enhanced ultrasound in the char-acterization of focal liver lesion[J].Eur Razdiol,2001.11(Supple 3):E27-34.
  • 4[4]Harvey,CJ,Pilcher JM,Eckersley RJ,et al.Advances in Ultra-sound[J].Clin Radiol,2002,57(3):157-177.
  • 5[5]Immer FF,Seiler AM,Aeschbacher BC,et al.Influence of the ultrasound contrast agent Levovist on human nailfold capillary mi-crocirculation[J].Angiology,2000,51(2):193-199.
  • 6[6]Less JR,Skalak TC,Sevick EM,et al.Microvascular archi-tecturc in a mammary carcinoma:branching patterns and vessel dimensions[J].Cancer Res,1991,51(1):265-273.
  • 7[7]D'Arey T J,Jayaram V,Lynch M,et al Ovarian cancel-de-tected non-invasively by contrast enhanced power Doppler ultra-sound[J].Br Obstet Gynecol,2004,111(6):619-622.
  • 8戴晴,刘真真,姜玉新,杨佳欣,吕珂,冷金花,高嫔.经阴道超声造影在附件包块诊断中的应用研究[J].中华超声影像学杂志,2006,15(9):693-697. 被引量:38
  • 9[9]Testa AC,Ferrandina G.Fruscella E,et al The use of con-trasted transvaginal sonography in the diagnosis of gynecologic diseases:a preliminary study[J].J Ultrasound Med,2005,24(9):1267-1278.
  • 10[10]Kohzuki M,Kanzaki T,Murata Y.Contrast-enhanced power Doppler sonography of malignant ovarian tumors using harmonic flash-echo imaging:Preliminary experience[J].Clin Ultra-sound,2005,33(5):237-242.

二级参考文献12

  • 1Bartolotta TV,Midiri M,Quaia E,etal.Focal liver lesions:spectrum of findings on SonoVue-enhanced pulse-inversionultrasonography.Eur Radiol,2005,15:1643-1649.
  • 2Nicolau C,Catalá V,Vilana R,et al.Evaluation of hepatocellular carcinoma usingSonoVue,a second generation ultrasound contrast agent:correlation with cellulardifferentiation.Eur Radiol,2004,14:1092-1099.
  • 3Abramowicz JS.Ultrasonographic contrast media:has the time come in obstetrics andgynecology? J Ultrasound Med,2005,24:517-531.
  • 4D'Arcy TJ,Jayaram V,Lynch M,et al.Ovarian cancer detected non-invasively bycontrast-enhanced power Doppler ultrasound.Br J Obstet Gynecol,2004,111:619-622.
  • 5Folkman J.Tumor angiogenesis.Adv Cancer Res,1985,43:174-176.
  • 6Burns PN,Wilson SR,Simpson DH,et al.Pulse inversion imaging of liver bloodflow:improved method for characterizing focal masses with microbubble contrast.InvestRadiol,2000,35:58-71.
  • 7Marret H,Sauget S,Giraudeau B,et al.Contrast-enhanced sonography helps indiscrimination of benign from malignant adnexal masses.J Ultrasound Med,2004,23:1629-1639.
  • 8Ordén MR,Jurvelin JS,Kirkinen P.Kinetics of a US contrast agent in benign andmalignant adnexal tumors.Radiology,2003,226:405-410.
  • 9Testa AC,Ferrandina G,Ferrandina E,et al.The use of contrasted transvaginal sonographyin the diagnosis of gynecologic diseases.J Ultrasound Med,2005,24:1267-1278.
  • 10Liang HD,Blomley MJK.The role of ultrasound in molecular imaging.Br JRadiol,2003,76:140-150.

共引文献37

同被引文献70

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部